250 related articles for article (PubMed ID: 32569606)
1. Adrenomedullin - Current perspective on a peptide hormone with significant therapeutic potential.
Fischer JP; Els-Heindl S; Beck-Sickinger AG
Peptides; 2020 Sep; 131():170347. PubMed ID: 32569606
[TBL] [Abstract][Full Text] [Related]
2. Structure-function analyses reveal a triple β-turn receptor-bound conformation of adrenomedullin 2/intermedin and enable peptide antagonist design.
Roehrkasse AM; Booe JM; Lee SM; Warner ML; Pioszak AA
J Biol Chem; 2018 Oct; 293(41):15840-15854. PubMed ID: 30139742
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin - new perspectives of a potent peptide hormone.
Schönauer R; Els-Heindl S; Beck-Sickinger AG
J Pept Sci; 2017 Jul; 23(7-8):472-485. PubMed ID: 28150464
[TBL] [Abstract][Full Text] [Related]
4. Evidence for Conservation of the Calcitonin Superfamily and Activity-regulating Mechanisms in the Basal Chordate Branchiostoma floridae: INSIGHTS INTO THE MOLECULAR AND FUNCTIONAL EVOLUTION IN CHORDATES.
Sekiguchi T; Kuwasako K; Ogasawara M; Takahashi H; Matsubara S; Osugi T; Muramatsu I; Sasayama Y; Suzuki N; Satake H
J Biol Chem; 2016 Jan; 291(5):2345-56. PubMed ID: 26644465
[TBL] [Abstract][Full Text] [Related]
5. Receptor activity-modifying protein-dependent effects of mutations in the calcitonin receptor-like receptor: implications for adrenomedullin and calcitonin gene-related peptide pharmacology.
Watkins HA; Walker CS; Ly KN; Bailey RJ; Barwell J; Poyner DR; Hay DL
Br J Pharmacol; 2014 Feb; 171(3):772-88. PubMed ID: 24199627
[TBL] [Abstract][Full Text] [Related]
6. Cloning, characterization and central nervous system distribution of receptor activity modifying proteins in the rat.
Oliver KR; Kane SA; Salvatore CA; Mallee JJ; Kinsey AM; Koblan KS; Keyvan-Fouladi N; Heavens RP; Wainwright A; Jacobson M; Dickerson IM; Hill RG
Eur J Neurosci; 2001 Aug; 14(4):618-28. PubMed ID: 11556887
[TBL] [Abstract][Full Text] [Related]
7. Selective CGRP and adrenomedullin peptide binding by tethered RAMP-calcitonin receptor-like receptor extracellular domain fusion proteins.
Moad HE; Pioszak AA
Protein Sci; 2013 Dec; 22(12):1775-85. PubMed ID: 24115156
[TBL] [Abstract][Full Text] [Related]
8. Adrenomedullin 2/intermedin is a slow off-rate, long-acting endogenous agonist of the adrenomedullin
Babin KM; Karim JA; Gordon PH; Lennon J; Dickson A; Pioszak AA
J Biol Chem; 2023 Jun; 299(6):104785. PubMed ID: 37146967
[TBL] [Abstract][Full Text] [Related]
9. Amylin, calcitonin gene-related peptide, calcitonin, and adrenomedullin: a peptide superfamily.
Wimalawansa SJ
Crit Rev Neurobiol; 1997; 11(2-3):167-239. PubMed ID: 9209829
[TBL] [Abstract][Full Text] [Related]
10. Protective effects of intermedin on cardiovascular, pulmonary and renal diseases: comparison with adrenomedullin and CGRP.
Holmes D; Campbell M; Harbinson M; Bell D
Curr Protein Pept Sci; 2013 Jun; 14(4):294-329. PubMed ID: 23745696
[TBL] [Abstract][Full Text] [Related]
11. Shared and separate functions of the RAMP-based adrenomedullin receptors.
Kuwasako K; Kitamura K; Nagata S; Hikosaka T; Takei Y; Kato J
Peptides; 2011 Jul; 32(7):1540-50. PubMed ID: 21645567
[TBL] [Abstract][Full Text] [Related]
12. The Impact of Adrenomedullin Thr22 on Selectivity within the Calcitonin Receptor-like Receptor/Receptor Activity-Modifying Protein System.
Fischer JP; Els-Heindl S; Schönauer R; Bierer D; Köbberling J; Riedl B; Beck-Sickinger AG
ChemMedChem; 2018 Sep; 13(17):1797-1805. PubMed ID: 29979487
[TBL] [Abstract][Full Text] [Related]
13. Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs.
Woolley MJ; Reynolds CA; Simms J; Walker CS; Mobarec JC; Garelja ML; Conner AC; Poyner DR; Hay DL
Biochem Pharmacol; 2017 Oct; 142():96-110. PubMed ID: 28705698
[TBL] [Abstract][Full Text] [Related]
14. Spatial expression of components of a calcitonin receptor-like receptor (CRL) signalling system (CRL, calcitonin gene-related peptide, adrenomedullin, adrenomedullin-2/intermedin) in mouse and human heart valves.
Pfeil U; Bharathala S; Murtaza G; Mermer P; Papadakis T; Boening A; Kummer W
Cell Tissue Res; 2016 Dec; 366(3):587-599. PubMed ID: 27553639
[TBL] [Abstract][Full Text] [Related]
15. Structural Basis for Receptor Activity-Modifying Protein-Dependent Selective Peptide Recognition by a G Protein-Coupled Receptor.
Booe JM; Walker CS; Barwell J; Kuteyi G; Simms J; Jamaluddin MA; Warner ML; Bill RM; Harris PW; Brimble MA; Poyner DR; Hay DL; Pioszak AA
Mol Cell; 2015 Jun; 58(6):1040-52. PubMed ID: 25982113
[TBL] [Abstract][Full Text] [Related]
16. Probing the Mechanism of Receptor Activity-Modifying Protein Modulation of GPCR Ligand Selectivity through Rational Design of Potent Adrenomedullin and Calcitonin Gene-Related Peptide Antagonists.
Booe JM; Warner ML; Roehrkasse AM; Hay DL; Pioszak AA
Mol Pharmacol; 2018 Apr; 93(4):355-367. PubMed ID: 29363552
[TBL] [Abstract][Full Text] [Related]
17. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes.
Roh J; Chang CL; Bhalla A; Klein C; Hsu SY
J Biol Chem; 2004 Feb; 279(8):7264-74. PubMed ID: 14615490
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular effects of exogenous adrenomedullin and CGRP in Ramp and Calcrl deficient mice.
Pawlak JB; Wetzel-Strong SE; Dunn MK; Caron KM
Peptides; 2017 Feb; 88():1-7. PubMed ID: 27940069
[TBL] [Abstract][Full Text] [Related]
19. The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism.
Naot D; Cornish J
Bone; 2008 Nov; 43(5):813-8. PubMed ID: 18687416
[TBL] [Abstract][Full Text] [Related]
20. Regulation of adrenomedullin and its family peptide by RAMP system--lessons from genetically engineered mice.
Shindo T; Sakurai T; Kamiyoshi A; Ichikawa-Shindo Y; Shimoyama N; Iinuma N; Arai T; Miyagawa S
Curr Protein Pept Sci; 2013 Aug; 14(5):347-57. PubMed ID: 23745699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]